首页> 外文期刊>JAMA: the Journal of the American Medical Association >Quality of reporting of randomized trials as a measure of methodologic quality.
【24h】

Quality of reporting of randomized trials as a measure of methodologic quality.

机译:报告随机试验的质量,作为方法学质量的度量。

获取原文
获取原文并翻译 | 示例
       

摘要

CONTEXT: The evaluation of the methodologic quality of randomized controlled trials (RCTs) is central to evidence-based health care. Important methodologic detail may, however, be omitted from published reports, and the quality of reporting is therefore often used as a proxy measure for methodologic quality. We examined the relationship between reporting quality and methodologic quality of published RCTs. METHODS: Study of 60 reports of placebo-controlled trials published in English-language journals from 1985 to 1997. Reporting quality was measured using a 25-item scale based on the 1996 issue of the Consolidated Standards of Reporting Trials (CONSORT). Concealment of allocation, appropriate blinding, and analysis according to the intention-to-treat principle were indicators of methodologic quality. Methodologic quality was compared between groups of trials defined by reporting quality scores of low, intermediate, and high. Reporting quality scores were compared between groups defined by high and low methodologic quality. RESULTS: Among 23 trials of low reporting quality (median score, 9 [range, 3.5-10.5]), allocation concealment was unclear for all but 1 trial, but there were 16 trials (70%) with adequate blinding and 9 trials (39%) that had been analyzed according to the intention-to-treat principle. Among 18 trials of high reporting quality (median score, 18 [range 16.5-22.0]), there were 8 trials (44%) with adequate allocation concealment, 16 trials (89%) with adequate blinding, and 13 trials (72%) analyzed according to the intention-to-treat principle. The median reporting score was 15.0 for the 33 trials that were analyzed according to intention-to-treat principle and 14.5 for the 14 trials with on-treatment analyses (P =.67). CONCLUSIONS: Similar quality of reporting may hide important differences in methodologic quality, and well-conducted trials may be reported badly. A clear distinction should be made between these 2 dimensions of the quality of RCTs.
机译:背景:对随机对照试验(RCT)的方法学质量的评估对于基于证据的医疗保健至关重要。但是,重要的方法学细节可能会从已发布的报告中省略,因此,报告质量经常被用作方法学质量的代理指标。我们检查了报告的质量和已发布的RCT的方法学质量之间的关系。方法:研究1985年至1997年在英语期刊上发表的60份安慰剂对照试验报告。根据1996年版的《试验报告合并标准》,采用25个项目的量表对报告质量进行了测量。分配的隐蔽性,适当的盲法和按照意向性治疗原则进行的分析是方法学质量的指标。比较了通过报告低,中和高质量得分定义的试验组之间的方法学质量。比较通过高和低方法学质量定义的各组之间的报告质量得分。结果:在23项报告质量低的试验中(中位评分,9 [范围,3.5-10.5]),除1项试验外,其他所有人的掩盖隐匿性均不清楚,但有16项试验(70%)具有足够的盲法和9项试验(39项) %)已根据意向治疗原则进行了分析。在18项报告质量高的试验中(中位数,18项[范围16.5-22.0]),其中8项试验(44%)具有适当的分配隐藏,16项试验(89%)有足够的盲法,13项试验(72%)根据意向治疗原则进行分析。根据意向性治疗原则进行分析的33项试验的中位报告得分为15.0,接受治疗分析的14项试验的中位报告得分为14.5(P = .67)。结论:类似的报告质量可能掩盖了方法学质量的重要差异,并且进行良好的试验可能被错误地报告。在RCT质量的这两个维度之间应该有明显的区别。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号